These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 33499267)
1. Evaluation of Nanotargeted Liu SY; Lo SN; Lee WC; Hsu WC; Lee TW; Chang CH Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499267 [TBL] [Abstract][Full Text] [Related]
3. The relationship between the cyclic-RGDfK ligand and αvβ3 integrin receptor. Mondal G; Barui S; Chaudhuri A Biomaterials; 2013 Aug; 34(26):6249-60. PubMed ID: 23702147 [TBL] [Abstract][Full Text] [Related]
4. Imaging integrin αvβ3 on blood vessels with 111In-RGD2 in head and neck tumor xenografts. Terry SY; Abiraj K; Frielink C; van Dijk LK; Bussink J; Oyen WJ; Boerman OC J Nucl Med; 2014 Feb; 55(2):281-6. PubMed ID: 24408894 [TBL] [Abstract][Full Text] [Related]
5. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma. Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312 [TBL] [Abstract][Full Text] [Related]
6. Preclinical SPECT Imaging of Choroidal Neovascularization in Mice Using Integrin-Binding [ Ahn SJ; Lee HY; Hong HK; Jung JH; Park JH; Park KH; Kim SE; Woo SJ; Lee BC Mol Imaging Biol; 2019 Aug; 21(4):644-653. PubMed ID: 30460625 [TBL] [Abstract][Full Text] [Related]
7. αVβ3 Integrin-Targeted Radionuclide Therapy with 64Cu-cyclam-RAFT-c(-RGDfK-)4. Jin ZH; Furukawa T; Degardin M; Sugyo A; Tsuji AB; Yamasaki T; Kawamura K; Fujibayashi Y; Zhang MR; Boturyn D; Dumy P; Saga T Mol Cancer Ther; 2016 Sep; 15(9):2076-85. PubMed ID: 27422811 [TBL] [Abstract][Full Text] [Related]
8. MR/NIRF Dual-Mode Imaging of αvβ3 Integrin-Overexpressing Tumors Using a Lipopeptide-Based Contrast Agent. Wang Q; Huang L; Zhu X; Zhou Y; Wang J; Su D; Liu L Mol Pharm; 2021 Dec; 18(12):4543-4552. PubMed ID: 34677979 [TBL] [Abstract][Full Text] [Related]
9. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model. Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640 [TBL] [Abstract][Full Text] [Related]
10. Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide. Dijkgraaf I; Liu S; Kruijtzer JA; Soede AC; Oyen WJ; Liskamp RM; Corstens FH; Boerman OC Nucl Med Biol; 2007 Jan; 34(1):29-35. PubMed ID: 17210459 [TBL] [Abstract][Full Text] [Related]
11. Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe. Li C; Wang W; Wu Q; Ke S; Houston J; Sevick-Muraca E; Dong L; Chow D; Charnsangavej C; Gelovani JG Nucl Med Biol; 2006 Apr; 33(3):349-58. PubMed ID: 16631083 [TBL] [Abstract][Full Text] [Related]
12. Imaging of Integrin α Song YS; Park HS; Lee BC; Jung JH; Lee HY; Kim SE Cancer Biother Radiopharm; 2017 Oct; 32(8):288-296. PubMed ID: 29053416 [TBL] [Abstract][Full Text] [Related]
13. alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide. Yoshimoto M; Ogawa K; Washiyama K; Shikano N; Mori H; Amano R; Kawai K Int J Cancer; 2008 Aug; 123(3):709-15. PubMed ID: 18498129 [TBL] [Abstract][Full Text] [Related]
14. Micro-positron emission tomography/contrast-enhanced computed tomography imaging of orthotopic pancreatic tumor-bearing mice using the αvβ₃ integrin tracer ⁶⁴Cu-labeled cyclam-RAFT-c(-RGDfK-)₄. Aung W; Jin ZH; Furukawa T; Claron M; Boturyn D; Sogawa C; Tsuji AB; Wakizaka H; Fukumura T; Fujibayashi Y; Dumy P; Saga T Mol Imaging; 2013 Sep; 12(6):376-87. PubMed ID: 23981783 [TBL] [Abstract][Full Text] [Related]
16. Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region. Amin M; Mansourian M; Koning GA; Badiee A; Jaafari MR; Ten Hagen TLM J Control Release; 2015 Dec; 220(Pt A):308-315. PubMed ID: 26526970 [TBL] [Abstract][Full Text] [Related]
17. Comparison of biological properties of (111)In-labeled dimeric cyclic RGD peptides. Zheng Y; Ji S; Tomaselli E; Yang Y; Liu S Nucl Med Biol; 2015 Feb; 42(2):137-45. PubMed ID: 25459111 [TBL] [Abstract][Full Text] [Related]
18. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB. Chen C; Duan Z; Yuan Y; Li R; Pang L; Liang J; Xu X; Wang J ACS Appl Mater Interfaces; 2017 Feb; 9(7):5864-5873. PubMed ID: 28128553 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of a novel adapter lipid derivative for preparation of cyclic peptide-modified PEGylated liposomes: Application of cyclic RGD peptide. Kato N; Sato T; Fuchigami Y; Suga T; Geng L; Tsurumaru M; Hagimori M; Mukai H; Kawakami S Eur J Pharm Sci; 2022 Sep; 176():106239. PubMed ID: 35714942 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃. Hernandez R; Czerwinski A; Chakravarty R; Graves SA; Yang Y; England CG; Nickles RJ; Valenzuela F; Cai W Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1859-68. PubMed ID: 26016906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]